Dysmetabolic Syndrome in a Man with a Novel Mutation of the Aromatase Gene: Effects of Testosterone, Alendronate, and Estradiol Treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 1, 2004, Pages 61-70

  Maffei, Laura ^a   Murata, Yoko ^e   Rochira, Vincenzo ^c   Tubert, Gloria ^a   Aranda, Claudio ^b   Vazquez, Marcela ^b   Clyne, Colin D ^e   Davis, Susan ^d   Simpson, Evan R ^e   Carani, Cesare ^c,f  

^a Consultorios Asociados Endocrinol ^*  (Argentina)

^b Tomografia Computada Buenos Aires TCBA   (Argentina)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d Jean Hailes Foundation for Women's Health   (Australia)

^e HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANDROGEN; AROMATASE; ESTRADIOL; ESTROGEN; GLUCOSE; GONADOTROPIN; LIPID; TESTOSTERONE ENANTATE;

ACANTHOSIS NIGRICANS; ADULT; ATHEROGENESIS; BONE MATURATION; CASE REPORT; CONFERENCE PAPER; DYSMETABOLIC SYNDROME; ENZYME DEFICIENCY; GENE MUTATION; GLUCOSE BLOOD LEVEL; GONADOTROPIN RELEASE; HEPATITIS; HOMOZYGOSITY; HUMAN; INSULIN RESISTANCE; MALE; MALE GENITAL SYSTEM; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; RISK FACTOR; TESTIS;

ACANTHOSIS NIGRICANS; ADULT; ALENDRONATE; AROMATASE; ARTERIOSCLEROSIS; BONE AND BONES; CRYPTORCHIDISM; DIABETES MELLITUS, TYPE 2; ESTRADIOL; FATTY LIVER; FOLLICLE STIMULATING HORMONE; HUMANS; INSULIN RESISTANCE; LIPIDS; LIVER; LUTEINIZING HORMONE; MALE; MUTATION; PAIN; SYNDROME; TESTIS; TESTOSTERONE;

EID: 10744225853     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030313     Document Type: Conference Paper

References (44)

1. Oz OK, Zerwekh JE, Fisher C, Graves K, Nanu L, Millsaps R, Simpson ER 2000 Bone has a sexually dimorphic response to aromatase deficiency. J Bone Miner Res 15:507-514
2. Couse JF, Korach KS 1999 Estrogen receptor null mice: what we learned and where will they lead us? Endocr Rev 20:358-417
3. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061
4. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698
5. Carani C, Qin K, Simoni M, Faustini Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER 1997 Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91-95
6. Bilezikian JF, Morishima A, Bell J, Grumbach MM 1998 Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 339:599-603
7. Rochira V, Faustini-Fustini M, Balestrieri A, Carani C 2000 Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. J Clin Endocrinol Metab 85:1841-1845
8. Herrmann BL, Saller B, Janssen OE, Gocke P, Bockisch A, Sperling H, Mann K, Broecker M 2002 Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 87:5476-5484
9. Faustini-Fustini M, Rochira V, Carani C 1999 Oestrogen deficiency in men: where are we today? Eur J Endocrinol 140:111-129
10. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S 2000 Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553-1560
11. Amin S, Zhang Y, Sawin CT, Evans SR, Hannan MT, Kiel DP, Wilson PW, Felson DT 2000 Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med 133:951-963
12. Khosla S 2002 Oestrogen, bones and men: when testosterone just isn't enough. Clin Endocrinol 56:291-293
13. Rochira V, Balestrieri A, Faustini-Fustini M, Borgato S, Beck-Peccoz P, Carani C 2002 Pituitary function in a man with congenital aromatase deficiency: effect of different doses of transdermal E2 on basal and stimulated pituitary hormones. J Clin Endocrinol Metab 87:2857-2862
14. Mauras N, O'Brien KO, Klein KO, Hayes V 2000 Estrogen suppression in males: metabolic effects. J Clin Endocrinol Metab 85:2370-2377
15. Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley Jr WF 2000 Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab 85:3027-3035
16. Mullis PE, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H 1997 Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab 82:1739-1745
17. Corbin CJ, Graham-Lorence S, McPhaul M, Mason JI, Mendelson CR, Simpson ER 1988 Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. Proc Natl Acad Sci USA 85:8948-8952
18. Ackerman GE, Smith ME, Mendelson CR, MacDonald PC, Simpson ER 1981 Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab 53:412-417
19. Weise M, De-Levi S, Barnes KM, Gafni RI, Abad V, Baron J 2001 Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci USA 98:6871-6876
20. Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A 2000 Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604-610
21. Grumbach MM, Auchus RJ 1999 Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 84:4677-4694
22. Recker RR, Heaney RP 2001 Editorial: the role of combination treatment for osteoporosis. J Clin Endocrinol Metab 86:1888-1889
23. Rochira V, Balestrieri A, Madeo B, Spaggiari A, Carani C 2002 Congenital estrogen deficiency in men: a new syndrome with different phenotypes; clinical and therapeutic implications in men. Mol Cell Endocrinol 193:19-28
24. Hayes FJ, Decruz S, Seminara SB, Boepple PE, Crowley WF 2001 Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J Clin Endocrinol Metab 86:53-58
25. Pura M, Mittre H, Carreau S, Kottler ML Clinical findings in an adult man with a novel mutation in the aromatase gene. Program of the 85th Annual Meeting of The Endocrine Society, Philadelphia, PA, 2003, p 243 (Abstract P1-467)
26. Main KM, Schmidt IM, Toppari J, Skakkebaek NE 2002 Early postnatal treatment of hypogonadotropic hypogonadism with recombinant human FSH and LH. Eur J Endocrinol 146:75-79
27. Donaldson KM, Tong SY, Washburn T, Lubhan DB, Eddy EM, Hutson JM, Korach KS 1996 Morphometric study of the gubemaculum in male estrogen receptor mutant mice. J Androl 17:91-95
28. Singh AB, Hsia S, Alaupovic P, Sinha-Hikim I, Woodhouse L, Buchanan TA, Shen R, Bross R, Berman N, Bhasin S 2002 The effects of varying doses of T on Insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab 87:136-143
29. Takeda K, Toda K, Saibara T, Nakagawa M, Saika K, Onishi T, Sugiura T, Shizuta Y 2003 Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 176: 237-246
30. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER 2000 Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97:12735-12740
31. Marchesini G, Brizi M, Morselli-Labate AM, Blanchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N 1999 Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107:450-455
32. Asscheman H, Gooren LJ, Megens JA, Nauta J, Kloosterboer HJ, Eikelboom F 1994 Serum testosterone level is the major determinant of the male-female differences in serum levels of high-density lipoprotein (HDL) cholesterol and HDL2 cholesterol. Metabolism 43:935-939
33. von Eckardstein A, Kliesch S, Nieschlag E, Chirazi A, Assmann G, Behre HM 1997 Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a). J Clin Endocrinol Metab 82:3367-3372
34. Sudhir K, Chou TM, Chatterjee K, Smith EP, Williams TC, Kane JP, Malloy MJ, Korach KS, Rubanyi GM 1997 Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 96:3774-3777
35. Sudhir K, Chou TM, Messina LM, Hutchinson SJ, Korach KS, Chatterjee K, Rubanyi GM 1997 Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet 349:1146-1147
36. Christian RC, Harrington S, Edwards WD, Oberg AL, Fitzpatrick LA 2002 Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women. J Clin Endocrinol Metab 87:1062-1067
37. Sudhir K, Komesaroff PA 1999 Cardiovascular actions of estrogens in men. J Clin Endocrinol Metab 84:3411-3415
38. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811
39. Lombardi G, Zarrilli S, Colao A, Paesano L, Di Somma C, Rossi F, De Rosa M 2001 Estrogens and health in males. Mol Cell Endocrinol 178:51-55
40. Komesaroff PA, Black CV, Westerman RA 1998 A novel, nongenomic action of estrogen on the cardiovascular system. J Clin Endocrinol Metab 83:2313-2316
41. Nemoto Y, Toda K, Ono M, Fujikawa-Adachi K, Saibara T, Onishi S, Enzan H, Okada T, Shizuta Y 2000 Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest 105:1819-1825
42. Elsheikh M, Hodgson HJ, Wass JA, Conway GS 2001 Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clin Endocrinol 55:227-231
43. Raman JD, Schlegel PN 2002 Aromatase inhibitors for male infertility. J Urol 167:624-629
44. Murata Y, Ogawa Y, Saibara T, Nishioka A, Fujiwara Y, Fukumoto M, Inomata T, Enzan H, Onishi S, Yoshida S 2000 Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients. Oncol Rep 7:1299-1304